SynthesisBMC cancer2024

Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

Danxue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.